Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.90.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-1.17
EARNINGS PER SHARE (EPS) AVG 3Y
-1.46
EARNINGS PER SHARE (EPS) AVG 5Y
-1.36
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Pulsenmore Ltd. Ordinary Shares
Market Cap
$14.11M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.17
3Y Avg
-1.46
5Y Avg
-1.36
Market Cap
$14.11M
Earnings Per Share (EPS)
-29.90
TTM Avg
-175.25
3Y Avg
-40254.86
5Y Avg
-180507.78
Market Cap
$13.81M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.73M
Earnings Per Share (EPS)
-5.41
TTM Avg
-10.52
3Y Avg
-27.78
5Y Avg
-33.88
Market Cap
$13.48M
Earnings Per Share (EPS)
-1.39
TTM Avg
-1.16
3Y Avg
-1.40
5Y Avg
-1.09
Market Cap
$13.37M
Earnings Per Share (EPS)
-2.11
TTM Avg
-3.38
3Y Avg
-4.90
5Y Avg
-6.31
Market Cap
$13.33M
Earnings Per Share (EPS)
-1.87
TTM Avg
-10.75
3Y Avg
-23.11
5Y Avg
-21.98
Market Cap
$14.96M
Earnings Per Share (EPS)
-13.07
TTM Avg
-13.67
3Y Avg
-19.10
5Y Avg
-23.67
Market Cap
$15.03M
Earnings Per Share (EPS)
-2.46
TTM Avg
-7.80
3Y Avg
-9.74
5Y Avg
-7.20
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulsenmore Ltd. Ordinary Shares (PLSM) | $14.11M | N/A | -1.17 | -1.46 | -1.36 |
| Vyome Holdings, Inc. (HIND)vs › | $14.11M | -29.90 | -175.25 | -40254.86 | -180507.78 |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.81M | N/A | N/A | N/A | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.73M | -5.41 | -10.52 | -27.78 | -33.88 |
| Optimi Health Corp. (OPTH)vs › | $13.48M | -1.39 | -1.16 | -1.40 | -1.09 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.37M | -2.11 | -3.38 | -4.90 | -6.31 |
| IN8bio, Inc. (INAB)vs › | $13.33M | -1.87 | -10.75 | -23.11 | -21.98 |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.96M | -13.07 | -13.67 | -19.10 | -23.67 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.03M | -2.46 | -7.80 | -9.74 | -7.20 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.24M | -0.77 | -1.25 | -1.82 | -1.86 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.78 |
| 2024-12-31 | -1.57 |
| 2023-12-31 | -2.50 |
| 2022-12-31 | -1.02 |
| 2021-12-31 | -1.61 |
| 2020-12-31 | -0.69 |
| 2019-12-31 | -0.22 |
